Apostherapy Israel

Hospitals and Health Care · 51 Employees
Phone Number: 97299615111
  • Overview
  • Job Postings
  • Employees
Access 8 Verified Employees Profiles for Apostherapy IsraelUnlock Free Contacts Now
About
AposTherapy is a clinically proven, FDA cleared, solution for knee and lower back pain—without the need for surgery, injections, opioids or changing patients’ daily routine. It addresses the root cause of the pain by shifting the pressure from the painful area and by re-educating the muscles for a healthier walking pattern, even when not wearing the device. The treatment results in long-lasting improved mobility, high patients satisfaction rate, and economical benefits to payers, providers, and participating practitioners. AposTherapy is adopted by prestigious healthcare organizations and has demonstrated success with 80,000 patients treated worldwide consistently achieving exceptionally high consumer satisfaction scores. AposTherapy is currently available in the US, UK, Israel and Singapore.
Year Founded
2004
Social Media
LinkedinFacebook
Industry
Hospitals and Health Care
HQ Location
Abba Eban Blvd 1 Herzliya, IL
Keywords
knee pailower back paihip paikle problems
Location
6
  • Abba Eban Blvd 1 Herzliya, IL
  • 9 Leo Stein St. Haifa, IL
  • Yitshak Rabin Boulevard 21 Afula, IL
  • Ha-Histadrut St 2 Ashkelon, IL
  • Hamarpe 1 st. Har-Hotzvim shopping center Jerusalem, IL
  • Sami Tarif building Maghar, IL

Email Formats

Sign up for free credits and discover verified email addresses of Apostherapy Israel
FormatExamples
first + last
andywarhol@co.il
first_initial + last
awarhol@co.il
first + last_initial
andyw@co.il
first
andy@co.il
last
warhol@co.il
Get Verified Emails for 8 Apostherapy Israel Employees

Frequently Asked Questions

Learn More about Apostherapy Israel
Key Contacts

Similar Companies

Hospitals and Health Care

Get key business info for Apostherapy Israel and other 100M companies. Start your seach.

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.